Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence.

CONCLUSION: Our data suggest that hydroxychloroquine may exert additional direct antiviral activity compared to chloroquine. In the absence of clinical studies comparing the efficacy of these two compounds, hydroxychloroquine may offer additional effects and may be considered as first choice.
PMID: 33302855 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Design - December 9, 2020 Category: Drugs & Pharmacology Authors: Ronsisvalle S, Panarello F, Di Mauro R, Bernardini R, Volti GL, Cantarella G Tags: Curr Pharm Des Source Type: research